Showing results (341-350 of 1,630) with videos related to

Sort By:
Pageof 163
Expert Review of Clinical Pharmacology|December 18, 2024
A systematic review and meta-analysis of users versus non-users: unveiling the influence of proton pump inhibitors on capecitabine efficacy in colorectal cancerFrancisco Cezar Aquino de Moraes, Estella Aparecida de Laia, Vitor Kendi Tsuchiya Sano, et al.
Expert Review of Clinical Pharmacology|January 31, 2025
Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis of randomized controlled trialsYiran Wang, Zonglin Li, Chu Lin, et al.
Expert Review of Clinical Pharmacology|January 6, 2025
Analysis of serum concentrations of metoprolol and its metabolite α-hydroxymetoprolol in patients with heart failure with reduced ejection fraction: a pilot study in routine health careIvana Kacirova, Marie Lazarova, Romana Urinovska, et al.
Expert Review of Clinical Pharmacology|January 31, 2025
Pharmacokinetics after bariatric surgery: adverse effects and drug safety issues in bariatric patientsDaniel Porat, Arik Dahan
Expert Review of Clinical Pharmacology|September 11, 2024
Oral complement factor D inhibitor danicopan for paroxysmal nocturnal hemoglobinuriaBo Xu, Jiecan Zhou
Expert Review of Clinical Pharmacology|November 26, 2024
Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysisHarmanjit Singh, Sangambir Kaur, Parul Kaushal, et al.
Expert Review of Clinical Pharmacology|November 16, 2023
Stimulant and hallucinogenic novel psychoactive substances; an updateF Schifano, A Vento, N Scherbaum, et al.
Expert Review of Clinical Pharmacology|October 21, 2023
The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver diseaseChara Tsiampali, Paraskevi Papaioannidou, Antonis Goulas, et al.
Expert Review of Clinical Pharmacology|October 21, 2023
The new evidence on cardiorenal benefits of sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: one step closer to their use in this setting?Djordje S Popovic, Theocharis Koufakis, Dimitrios Patoulias, et al.
Expert Review of Clinical Pharmacology|October 21, 2023
A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophreniaJie Wu, Angela Th Kwan, Taeho Greg Rhee, et al.
Pageof 163